Erythropoietin resistance: The role of inflammation and pro-inflammatory cytokines

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 11, 2002, Pages 39-43

  Macdougall, Iain C ^a   Cooper, Angela C ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Anti cytokine therapy; Chronic inflammation; Drug resistance; Recombinant human erythropoietin; Uraemia

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYANOCOBALAMIN; CYTOKINE; CYTOKINE ANTIBODY; FOLIC ACID; GAMMA INTERFERON; HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; IRON; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIALYSIS; DRUG ACTIVITY; DRUG RESPONSE; DRUG SENSITIVITY; ERYTHROPOIESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFECTION COMPLICATION; INFLAMMATION; IRON DEFICIENCY; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY DIAGNOSIS; MONOCYTE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; T LYMPHOCYTE; UREMIA;

EID: 0036413580     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_11.39     Document Type: Article

References (15)

1. Macdougall IC. Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transplant 1995; 10: 607-614
2. Drueke TB. R-HuEPO hyporesponsiveness: who and why? Nephrol Dial Transplant 1995; 10 [Suppl 2]: S62-S68
3. Danielson B. R-HuEPO hyporesponsiveness: who and why? Nephrol Dial Transplant 1995; 10 [Suppl 2]: S69-S73
4. Fishbane S. Hyporesponsiveness to recombinant human erythropoietin in dialysis patients. Dial Transplant 2000; 29: 545-548
5. Bergstrom J, Lindholm B, Lacson E Jr et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 2000; 13: 163-175
6. Hörl W, Jacobs C, Macdougall IC. European Survey on Anaemia Management (ESAM). Nephrol Dial Transplant 2000; 15 [Suppl 41]: 43-45
7. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 20: 1639-1647
8. Dai CH, Price JO, Brunner T, Kranz SB. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis. Blood 1998; 15: 1235-1242
9. Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by interferons α and β: differing mechanisms despite shared receptor. Exp Haematol 1996; 24: 204-208
10. Allen DA, Breen C, Yaqoob MM, Macdougall IC. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-γ and TNF-α. J Invest Med 1999; 47: 204-211
11. Macdougall IC, Cooper A. The inflammatory response and epoetin sensitivity. Nephrol Dial Transplant 2002; 17 [Suppl 1]: 48-52
12. Kimmel PL, Phillips TM, Simmens SJ et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54: 236-244
13. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int 2000; 58 [Suppl 76]: S104-S111
14. Gately MK, Renzetti LM, Magram J et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Ann Rev Immunol 1998; 16: 495-521
15. Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 2000; 15: 1207-1211